1URBA S G, ORRINGER M B, IANETTONNI M, et al. Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma [ J ] . Cancer, 2003, 98(10): 2177- 2183.
2POLEE M B, TILANUS H W, ESKENS F A. Phase Ⅱ study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus [ J ] . Ann Oncol, 2003, 14(8): 1253-1257.
3MCKEAGE M J. Lobaplatin: a new antitumour platinum drug [ J ] . Expert Opin Invest Drugs, 2001, 10(1): 119-128.
6NAKAGAWA S, KANDA T, KOSUGI S, et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy [ J ] . J Am Coil Surg, 2004, 198(2): 205- 211.
7SCHMOLL H J, KOHNE C H, PAPAGEORION E, et al. Single agent lobaplatin is active in patients with esophageal squamous cell carcinoma: a phase lI evaluation [ J ] . Proc ASCO, 1995, 14: 483.
